SRRK today
$46.60-$1.40 (-2.92%)close Nov 11, 2026Trend
DailyDowntrend (starting)
4 hourSymmetric Triangle
1 hourStrong Bearish
15 minStrong Bearish
5 minBearish
Daily trend turns up above $61.76
Key levels
Resistance$52.25
Resistance$48.77
Support$45.88
Support$42.89
Latest news & SEC filings
EarningsScholar Rock Holding holds Q3 2026 earnings call
EarningsScholar Rock Posts Q3 2026 Financial Results
DealBioNTech to pay Scholar Rock $205M for rare FDA fast-track voucher
EarningsScholar Rock posts smaller quarterly loss than expected, revenue tops view
All SRRK news →About Scholar Rock
Scholar Rock is a biopharmaceutical company that creates antibody medicines aimed at inactive precursor proteins within the TGF-beta family. Its main candidate, apitegromab, blocks myostatin and is being developed for spinal muscular atrophy and facioscapulohumeral muscular dystrophy, alongside SRK-439 and other earlier-stage programs for rare neuromuscular and other conditions. The company operates in the United States and Europe, focusing on patients with rare neuromuscular disorders.
Based on the company's 10-K filed Mar 3, 2026.
Nasdaq · Healthcare
Scholar Rock Holding Corp (SRRK)
What Is the Price Target for SRRK?
SEPT Low Target
$58.00
SEPT Mid Target
$70.00
SEPT High Target
$84.00
Analyst Consensus
$70.00
Is SRRK a Buy or Sell Right Now?
Thesis
- •Revenue growing 76.4% YoY with UNKNOWN trend — consistent growth.
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for SRRK.
Start Free Trial →Is SRRK Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$53.76
7
Moat Score
NONE
1/9
Piotroski Score
15.7
Altman Z-Score
What Is Smart Money Doing with SRRK?
Insider Signal
BUYING
6 buys / 1 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| AKKARAJU SRINIVAS | director | Buy | 48,988 | $2.0M | Oct 26, 2026 |
| AKKARAJU SRINIVAS | director | Buy | 97,982 | $4.1M | Oct 26, 2026 |
| AKKARAJU SRINIVAS | director | Buy | 47,000 | $1.9M | Oct 23, 2026 |
| AKKARAJU SRINIVAS | director | Buy | 94,000 | $3.9M | Oct 23, 2026 |
| AKKARAJU SRINIVAS | director | Buy | 500 | $21K | Oct 23, 2026 |
| AKKARAJU SRINIVAS | director | Buy | 1,000 | $42K | Oct 23, 2026 |
| Woods Keith | officer | Sale | 48,034 | - | Sep 24, 2026 |
| Hallal David | director officer | Sale | 36,652 | - | Sep 21, 2026 |
| FLIER JEFFREY S. | director | Buy | 6,839 | - | Jun 4, 2026 |
| Reed Joshua | director | Buy | 6,839 | - | Jun 4, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →SRRK Growth Story
Revenue YoY
76.4%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-33.2%
FCF Growth YoY
-49.5%
Revenue Trend
UNKNOWN
Dark Pool Trades for SRRK
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for SRRK, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 12:24:32 | $46.10 | 1,000 | $$46K | BUY |
| 12:21:24 | $46.10 | 1,500 | $$69K | BUY |
| 21:00:19 | $46.60 | 1,411 | $$66K | BUY |
| 21:00:19 | $46.60 | 1,409 | $$66K | BUY |
| 21:00:01 | $46.60 | 1,961 | $$91K | BUY |
5 dark pool trades shown · $$338K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for SRRK
PREVIEWSEPT Investing provides real-time options flow tracking for SRRK, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $85 | Jan 15 | 65 | $$20 | 4 | SWEEP |
| CALL | $85 | Jan 15 | 65 | $$35 | 7 | SWEEP |
| CALL | $85 | Jan 15 | 65 | $$25 | 5 | SWEEP |
| CALL | $85 | Jan 15 | 65 | $$30 | 6 | SWEEP |
| CALL | $85 | Jan 15 | 65 | $$35 | 7 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Scholar Rock Holding Corp (SRRK) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (5 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →SRRK — frequently asked questions
What is SRRK stock price today?
Scholar Rock Holding Corp (SRRK) is at $46.60, down 2.92% (-$1.40) at the Nov 11, 2026 close.
Why is SRRK stock down today?
Nov 10, 2026: Scholar Rock (SRRK) reported Q3 2026 results, posting a narrower-than-expected loss per share of $0.81 versus the $0.85 consensus, while revenue of $600,000 far exceeded the $22,429 estimate. The company also disclosed that BioNTech will pay $205 million in cash for a rare FDA fast-track voucher, a bullish contract development.
What is the SRRK price target?
The average analyst price target for SRRK is $70.00, ranging from $58 to $84, based on 13 analysts. Latest: Truist Securities maintains on Sep 24, 2026.
What do analysts rate SRRK?
Analyst ratings for SRRK: 0 Buy, 21 Hold, 1 Sell — consensus Hold.
Does SRRK pay a dividend?
SRRK does not currently pay a dividend.
What are SRRK support and resistance levels?
Support: $45.88, $42.89, $38.69. Resistance: $48.77, $52.25, $56.94.
What are insiders doing with SRRK?
Insider activity: BUYING, 6 buys and 1 sells in the last 90 days.
What is the latest news on SRRK?
Nov 10, 2026: Scholar Rock Holding holds Q3 2026 earnings call · Nov 10, 2026: Scholar Rock Posts Q3 2026 Financial Results · Nov 10, 2026: BioNTech to pay Scholar Rock $205M for rare FDA fast-track voucher